ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

NIH News: PubMed Central Is Name Of New NIH PLAN For Electronic Publishing

September 10, 1999

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

Letter: Weinstein’s Former Fellows Express “Shock” At Allegations

December 1, 1995